Bobby-Ernst Boursiquot

Title: Inventor Spotlight: Bobby-Ernst Boursiquot

Introduction: Bobby-Ernst Boursiquot, a talented inventor based in Laval, Canada, is recognized for his innovative work in the field of controlled release formulations to prevent misuse of pharmaceuticals.

Latest Patents: Bobby-Ernst Boursiquot has recently patented two groundbreaking inventions in the pharmaceutical industry. One of his patents is a misuse preventative, controlled release formulation that effectively retards the release of a pharmaceutically active agent, such as an opioid analgesic, when crushed. This unique formulation comprises a core with a superabsorbent material and controlled release microparticles, ensuring safe delivery of medication.

Career Highlights: With a total of four patents to his name, Bobby-Ernst Boursiquot has made significant contributions to pharmaceutical innovation. His focus on creating safer drug delivery systems showcases his dedication to improving healthcare practices and patient outcomes.

Collaborations: Bobby-Ernst Boursiquot has collaborated with esteemed colleagues in his career, including Miloud Rahmouni and Angela Ferrada. Together, they have worked on developing advanced pharmaceutical technologies aimed at enhancing the effectiveness and safety of medication usage.

Conclusion: Bobby-Ernst Boursiquot's inventive spirit and commitment to developing innovative solutions in the pharmaceutical field have positioned him as a standout inventor in Laval, Canada. His patents and collaborations underscore his impact on advancing healthcare practices and improving drug delivery mechanisms for the benefit of patients worldwide.